Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Aug 19, 2014

30339_dirs_2014-08-19_7e2e60d8-4635-4e4b-9492-60ee02b51c6d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-08-18

Reporting Person: FEDERICI WILLIAM J (Sr. VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-08-18 Common Stock M 38366.0000 $16.2925 Acquired 243826.4426 Direct
2014-08-18 Common Stock S 38366.0000 $42.5589 Disposed 205460.4426 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-08-18 Stock Option (Right to Buy) $16.2925 M 38366.0000 Disposed 2016-02-24 Common Stock (38366.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1020.2154 Indirect
Common Stock 3880.3276 Indirect

Footnotes

F1: The price of $42.5589 represents an average price ranging from $42.40 to $42.80. All the sale prices are available upon request.